On January 30, 2023, Apexigen, Inc. closed the transaction. The company issued 1,995,708 common shares at an issue price of $1.4 per share for aggregate gross proceeds of approximately $2,793,991.2. The transaction included participation from 13 investors. The company paid finder's fee of $45,000 for the transaction.
1st Jan change | Capi. | |
---|---|---|
+20.63% | 126B | |
+24.16% | 27.95B | |
-20.17% | 20.5B | |
-16.06% | 17.12B | |
-18.07% | 16.1B | |
-47.70% | 14.97B | |
+11.92% | 14.84B | |
+58.32% | 14.38B | |
+149.98% | 12.37B |